Beruflich Dokumente
Kultur Dokumente
Department of Surgery
Etiology
Jaundice
PREHEPATIC
HEPATIC
POSTHEPATIC
Etiology
Jaundice
PREHEPATIC
HEPATIC
POSTHEPATIC
Etiology
Jaundice
PREHEPATIC
HEPATIC
POSTHEPATIC
Etiology
Jaundice
PREHEPATIC
HEPATIC
POSTHEPATIC
Etiology
Jaundice
PREHEPATIC
HEPATIC
POSTHEPATIC
Etiology
Jaundice
PREHEPATIC
HEPATIC
POSTHEPATIC
Defective uptake
Etiology
Jaundice
PREHEPATIC
HEPATIC
POSTHEPATIC
Etiology
Jaundice
PREHEPATIC
HEPATIC
POSTHEPATIC
Etiology
Jaundice
PREHEPATIC
HEPATIC
POSTHEPATIC
Etiology
Jaundice
PREHEPATIC
HEPATIC
POSTHEPATIC
Treatment
Jaundice
PREHEPATIC
HEPATIC
POSTHEPATIC
MEDICAL
SURGICAL
What are reliable symptoms and signs (more than 90% certainty) that will indicate that patients with jaundice will need surgical treatment?
RUQ pain Jaundice Tea-colored urine/ pale stools Fever (+/-) RUQ tenderness No hepatomegaly
What are reliable symptoms and signs (more than 90% certainty) that a patient with obstructive jaundice needs urgent intervention?
Abdominal pain (70%) Jaundice (60%) Tea-colored urine/pale stools Altered mental status (10-20%) Hypotension (30%) Fever, persistent (90%) RUQ tenderness
If a paraclinical diagnostic procedure is needed in a patient with suspected obstructive jaundice, what is the most cost-effective procedure? Ultrasound
Goal of Treatment
Obstructive Jaundice Relief of Obstruction Prevent Complication Prevent Recurrence Ascending Cholangitis Prompt drainage Control infection
Treatment Options
Treatment ERCP Benefit -able to achieve primary treatment objective SR=71-98% CBD Clearance -bleeding -perforation -pancreatitis Risk Cost *12-15,000 pesos at Metropolita n Hospital *2-3,000 pesos at PGH *20-30,000 pesos in private hospitals *free to charity pxs at OM *40-60,000 pesos in private hospitals Availability Not available
Open surgery
available
Laparoscopic surgery
-complications of anesthesia -bleeding -iatrogenic injury to biliary ducts -trocar and needle insufflation injuries
Not available
Treatment Options
Treatment ERCP Benefit -able to achieve primary treatment objective SR=90-98% CBD decompression MtR=10% -bleeding -perforation -pancreatitis Risk Cost *12-15,000 pesos at Metropolita n Hospital *2-3,000 pesos at PGH 10000 Availability Not available
PTBD
SR=90% CBD decompression MtR=15% -able to achieve primary treatment objective SR=90-100% CBD MtR=32-40%
-bleeding
available
Open surgery
available
Boerma et al
120 patients aged 18 to 80 years with proved symptomatic common bile duct and concomitant gallbladder stones who underwent ES and bile duct clearance. Patients were randomized to:
LC within 6 weeks of endoscopic stone clearance wait and see approach.
Results
mean follow-up period of 30 months
47% of patients in the wait and see group had recurrent biliary symptoms compared with 2% in the LC group. 37% of the wait and see group needed cholecystectomy.
Targarona et al
randomized 98 elderly and other high-risk patients with symptoms likely caused by bile duct stones
ES alone open surgery
Result
mean follow-up of 17 months,
biliary symptoms recurred in 20% of the ES group and 6% of the surgery group.
Hammarstrom et al
randomized 83 patients with bile duct stones
ES and stone removal open surgery (cholecystectomy and bile duct exploration)
Result
after more than 5 years,
20% of the ES group underwent cholecystectomy because of recurrent biliary symptoms, 2% of patients in the surgery group had recurrent symptoms from bile duct stones. During the follow-up period, nonbiliary mortality was significantly more common in the ES group
Panis et al
randomized 206 patients with common bile duct stones
endoscopic therapy alone surgery
Result
early surgery was required in 19% in the endoscopic group, only 2% of the surgical group needed reoperation.
recommendation
patients with cholangitis should undergo elective Lap Chole after bile duct clearance if they are fit for surgery (unless an open approach is known to be required).